‘Genetic signatures’ may predict prostate cancer

blood test
Researchers have identified genetic “signatures” for aggressive prostate cancer (the second most common cause of death in men, after lung cancer). The findings could one day help improve patient treatment and outcomes. These genetic patterns were identified from simple blood tests, with no tissue or biopsy was needed.
Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Deaths from COVID-19 are far higher than reported estimates

Infographic: Deaths from COVID-19 are far higher than reported estimates

More than 2.8 million people have lost their lives due to the pandemic, according to a Wall Street Journal analysis ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend